Literature DB >> 25827139

Metformin should not be contraindicated in patients with type 2 diabetes and mild to moderate renal impairment.

André J Scheen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25827139     DOI： 10.1136/ebmed-2015-110184

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  2 in total

Review 1.  Metformin associated lactic acidosis (MALA): clinical profiling and management.

Authors:  Alessandra Moioli; Barbara Maresca; Andrea Manzione; Antonello Maria Napoletano; Daniela Coclite; Nicola Pirozzi; Giorgio Punzo; Paolo Menè
Journal:  J Nephrol       Date:  2016-01-22       Impact factor: 3.902

2.  Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed-Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin.

Authors:  Vaishali Sahasrabudhe; Daryl J Fediuk; Kyle Matschke; Haihong Shi; Yali Liang; Anne Hickman; Almasa Bass; Steven G Terra; Susan Zhou; Rajesh Krishna; Vikas K Dawra
Journal:  Clin Pharmacol Drug Dev       Date:  2018-11-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.